CLOS
ARRY

Compagnie Lombard Odier SCmA’s Array Biopharma Inc ARRY Stock Holding History

Compagnie Lombard Odier SCmA’s Portfolio ARRY Stock Details ARRY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q1 		– Sell
-1,000
Closed -$9K – 875
2016
Q4 		$9K Sell
1,000
-2,500
-71% -$18.4K ﹤0.01% 758
2016
Q3 		$24K Hold
3,500
– – ﹤0.01% 775
2016
Q2 		$12K Hold
3,500
– – ﹤0.01% 822
2016
Q1 		$10K Buy
+3,500
New +$10.5K ﹤0.01% 891

Other funds holding ARRY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
PA
Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Compagnie Lombard Odier SCmA's ARRY Position: Q1 2017 in Review

Compagnie Lombard Odier SCmA sold out of Array Biopharma Inc (ARRY) in Q1 2017, closing a stake of 1,000 shares — an estimated $9K sold.

Compagnie Lombard Odier SCmA first reported a position in ARRY in Q1 2016 and held it in 4 quarters. The position peaked at $24K in Q3 2016. 187 funds tracked by Wall St. Rank hold ARRY as of Q1 2017.

  • Compagnie Lombard Odier SCmA reported no remaining Array Biopharma Inc position as of Q1 2017 after selling out during the quarter.
  • Compagnie Lombard Odier SCmA sold 1,000 Array Biopharma Inc shares in Q1 2017, an estimated $9K.
  • Compagnie Lombard Odier SCmA first reported a position in Array Biopharma Inc in Q1 2016 and held it in 4 quarters.
  • Compagnie Lombard Odier SCmA's Array Biopharma Inc position peaked at $24K in Q3 2016.
  • 187 funds tracked by Wall St. Rank held Array Biopharma Inc as of Q1 2017.

Based on Compagnie Lombard Odier SCmA's 13F filing for Q1 2017, filed 15 May 2017.